ClinConnect ClinConnect Logo
Search / Trial NCT01148446

R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL

Launched by FONDAZIONE ITALIANA LINFOMI - ETS · Jun 21, 2010

Trial Information

Current as of June 14, 2025

Completed

Keywords

Dlbcl R Chop R Ceop Elderly Patients

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients with untreated DLBCL aged 66 to 80 years without major accompanying diseases and considered as "non frail".
  • 2. Patients were classified as "non frail" (fit) if they had
  • ADL (Activity of Daily Living) score of 6
  • less than three grade 3 Cumulative Illness Rating Score for Geriatrics (CIRS-G) co-morbidities and no grade 4 co-morbidities
  • absence of geriatric syndrome
  • 3. Patients HIV negativity;
  • 4. Concurrent malignancy;
  • 5. Written Informed Consent.
  • Exclusion Criteria:
  • All other patients were classified as "unfit", and were excluded from randomization

About Fondazione Italiana Linfomi Ets

Fondazione Italiana Linfomi - ETS is a leading research organization dedicated to advancing the understanding and treatment of lymphoid malignancies. With a focus on promoting clinical trials and innovative therapeutic approaches, the foundation collaborates with healthcare professionals, academic institutions, and pharmaceutical companies to enhance patient care and outcomes. Its mission encompasses fostering research initiatives, facilitating education, and supporting the development of new strategies to combat lymphomas, ultimately aiming to improve the quality of life for patients affected by these diseases.

Locations

Cosenza, , Italy

Lecce, , Italy

Modena, , Italy

Catania, , Italy

Civitanova Marche (Mc), , Italy

Correggio (Re), , Italy

Sassuolo (Mo), , Italy

Reggio Emilia, , Italy

Vigevano, Pavia, Italy

Brescia, , Italy

Torino, , Italy

Patients applied

0 patients applied

Trial Officials

Francesco Merli, MD

Study Chair

U.O.A. di Ematologia Azienda Ospedale S. Maria Nuova

Marilena Bertini, MD

Study Chair

U.O.A. di Ematologia Ospedale Molinette

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials